Heymans A - Search Results

1

Genetic and Epigenetic Modification of Rat Liver Progenitor Cells via HNF4α Transduction and 5' Azacytidine Treatment: An Integrated miRNA and mRNA Expression Profile Analysis.

Bolleyn J, Rombaut M, Nair N, Branson S, Heymans A, Chuah M, VandenDriessche T, Rogiers V, De Kock J, Vanhaecke T. Bolleyn J, et al. Among authors: heymans a. Genes (Basel). 2020 Apr 29;11(5):486. doi: 10.3390/genes11050486. Genes (Basel). 2020. PMID: 32365562 Free PMC article.

2

Evaluation of the multipotent character of human foreskin-derived precursor cells.

De Kock J, Snykers S, Ramboer E, Demeester S, Heymans A, Branson S, Vanhaecke T, Rogiers V. De Kock J, et al. Among authors: heymans a. Toxicol In Vitro. 2011 Sep;25(6):1191-202. doi: 10.1016/j.tiv.2011.03.013. Epub 2011 Mar 22. Toxicol In Vitro. 2011. PMID: 21435389

3

Evaluation of the multipotent character of human adipose tissue-derived stem cells isolated by Ficoll gradient centrifugation and red blood cell lysis treatment.

Al Battah F, De Kock J, Ramboer E, Heymans A, Vanhaecke T, Rogiers V, Snykers S. Al Battah F, et al. Among authors: heymans a. Toxicol In Vitro. 2011 Sep;25(6):1224-30. doi: 10.1016/j.tiv.2011.05.024. Epub 2011 May 27. Toxicol In Vitro. 2011. PMID: 21645610

4

Toxicogenomics-based prediction of acetaminophen-induced liver injury using human hepatic cell systems.

Rodrigues RM, Heymans A, De Boe V, Sachinidis A, Chaudhari U, Govaere O, Roskams T, Vanhaecke T, Rogiers V, De Kock J. Rodrigues RM, et al. Among authors: heymans a. Toxicol Lett. 2016 Jan 5;240(1):50-9. doi: 10.1016/j.toxlet.2015.10.014. Epub 2015 Oct 20. Toxicol Lett. 2016. PMID: 26497421

5

Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists.

Boeckmans J, Natale A, Rombaut M, Buyl K, Cami B, De Boe V, Heymans A, Rogiers V, De Kock J, Vanhaecke T, Rodrigues RM. Boeckmans J, et al. Among authors: heymans a. Cell Biol Toxicol. 2021 Apr;37(2):293-311. doi: 10.1007/s10565-020-09544-2. Epub 2020 Jul 1. Cell Biol Toxicol. 2021. PMID: 32613381

6

Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery.

Boeckmans J, Gatzios A, Heymans A, Rombaut M, Rogiers V, De Kock J, Vanhaecke T, Rodrigues RM. Boeckmans J, et al. Among authors: heymans a. Cells. 2022 Mar 4;11(5):893. doi: 10.3390/cells11050893. Cells. 2022. PMID: 35269515 Free PMC article.

7

A novel genotoxin-specific qPCR array based on the metabolically competent human HepaRG^™ cell line as a rapid and reliable tool for improved in vitro hazard assessment.

Ates G, Mertens B, Heymans A, Verschaeve L, Milushev D, Vanparys P, Roosens NHC, De Keersmaecker SCJ, Rogiers V, Doktorova TY. Ates G, et al. Among authors: heymans a. Arch Toxicol. 2018 Apr;92(4):1593-1608. doi: 10.1007/s00204-018-2172-5. Epub 2018 Feb 6. Arch Toxicol. 2018. PMID: 29411056

8

Testing chemical carcinogenicity by using a transcriptomics HepaRG-based model?

Doktorova TY, Yildirimman R, Ceelen L, Vilardell M, Vanhaecke T, Vinken M, Ates G, Heymans A, Gmuender H, Bort R, Corvi R, Phrakonkham P, Li R, Mouchet N, Chesne C, van Delft J, Kleinjans J, Castell J, Herwig R, Rogiers V. Doktorova TY, et al. Among authors: heymans a. EXCLI J. 2014 May 28;13:623-37. eCollection 2014. EXCLI J. 2014. PMID: 26417288 Free PMC article.

9

In silico tools and transcriptomics analyses in the mutagenicity assessment of cosmetic ingredients: a proof-of-principle on how to add weight to the evidence.

Ates G, Raitano G, Heymans A, Van Bossuyt M, Vanparys P, Mertens B, Chesne C, Roncaglioni A, Milushev D, Benfenati E, Rogiers V, Doktorova TY. Ates G, et al. Among authors: heymans a. Mutagenesis. 2016 Jul;31(4):453-61. doi: 10.1093/mutage/gew008. Epub 2016 Mar 15. Mutagenesis. 2016. PMID: 26980085

10

Evidence that variation in root anatomy contributes to local adaptation in Mexican native maize.

McLaughlin CM, Li M, Perryman M, Heymans A, Schneider H, Lasky JR, Sawers RJH. McLaughlin CM, et al. Among authors: heymans a. Evol Appl. 2024 Mar 10;17(3):e13673. doi: 10.1111/eva.13673. eCollection 2024 Mar. Evol Appl. 2024. PMID: 38468714 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page